Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alexion Breaks Ground on New Global Headquarters

Published: Wednesday, June 19, 2013
Last Updated: Wednesday, June 19, 2013
Bookmark and Share
Company joined officials in a ground-breaking ceremony for a state-of-the-art laboratory and office building that will house the company’s new global HQ.

The event marks a milestone in the expansion of Alexion’s research and business operations as it continues to develop a broad portfolio of life-transforming therapies for patients. In addition, construction of the new building in the Downtown Crossing section of New Haven is an important step in the revitalization of the city’s downtown neighbourhoods.

Alexion will be the anchor tenant in 100 College Street, occupying nine floors. The building is expected to be open for occupancy in 2015.

"Our new global headquarters will support our continued growth as we work to develop and deliver life-transforming therapies for patients with severe and life-threatening disorders that are also ultra-rare,” said Leonard Bell, MD, Chief Executive Officer of Alexion. “We are especially pleased by this step because our return to New Haven is a homecoming for our company, and we are able to take part in the redevelopment of the downtown area.”

When Alexion takes occupancy in 2015, it will mark the company’s return to the city where it was founded more than 20 years ago. Alexion plans to relocate more than 400 employees who are currently based in Connecticut to the new site in 2015. In addition, the company is well underway to adding the 200 to 300 new jobs it anticipated creating when it was admitted to Governor Dannel P. Malloy’s First Five program in June 2012.

Dr. Bell was joined at the groundbreaking ceremony by Governor Malloy, as well as by Sen. Richard Blumenthal, Rep. Rosa DeLauro, New Haven Mayor John DeStefano, Jr. and representatives from Yale University and Yale-New Haven Hospital.

“We are positioning Connecticut as a leader in the bioscience industry, and Alexion’s decision to build their new global headquarters in our state is a clear sign that the future in this sector is bright,” said Governor Dannel P. Malloy. “With our economic development tools, our focus on growing bioscience and technology, and through widely expanding higher education, we will continue to expand bioscience in Connecticut—creating good paying jobs with good benefits. These investments not only improve our economic strength and competitiveness, but also establish important partnerships between our universities, medical centers, and private sector businesses.”

The state-of-the-art 11-story office building is the first building to be erected as part of New Haven’s Downtown Crossing urban revitalization effort. Downtown Crossing is the largest infrastructure activity in New Haven in decades, and is funded by the U.S. Department of Transportation’s TIGER II grant, the city of New Haven and the State of Connecticut. It is expected to create 2,000 construction jobs, result in $184 million in direct and indirect spending over the next three years, and create 600 to 900 permanent jobs upon completion. The building is being constructed to be certifiable to an environmental standard of at least LEED Silver.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EU Recommends Approval for Alexion's Rare Disease Drugs
Alexion Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions recommending marketing authorization of Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).
Tuesday, June 30, 2015
Alexion Broadens and Strengthens its Executive Leadership Team
Company has expanding global mission to develop and commercialize life transforming therapies for patients with disorders that are severe, life-threatening, and ultra-rare.
Friday, April 26, 2013
Alexion's Antibody Therapy Shown Effective in Model for Severe Allergic Asthma
Findings show treatment with anti-C5 complement antibody reduced airway inflammation when used with standard nebulizer.
Tuesday, May 16, 2006
Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Playing 'Tag' with Pollution lets Scientists See Who's It
Using a climate model that can tag sources of soot from different global regions and can track where it lands on the Tibetan Plateau, researchers have determined which areas around the plateau contribute the most soot — and where.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
High-Resolution 3D Images Reveal the Muscle Mitochondrial Power Grid
NIH mouse study overturns scientific ideas on energy distribution in muscle.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!